Rate My Professor Roos Masereeuw

Prof. dr. Roos Masereeuw is Professor of Experimental Pharmacology and Chair in the Faculty of Science at Utrecht University, appointed full professor at the Department of Pharmaceutical Sciences in July 2015. She earned her M.Sc. in Biopharmaceutical Sciences from Leiden University in 1991 and her Ph.D. from Radboud University Nijmegen in 1997, with postdoctoral research at the National Institute of Environmental Health Sciences (NIEHS/NIH) in the USA. Masereeuw began her academic career as Assistant Professor in the Department of Pharmacology and Toxicology at Radboudumc in 1997, advancing to Associate Professor in 2002 after receiving the NWO Aspasia award. She also served as a reviewer for the Dutch Medicines Evaluation Board until 2000. At Utrecht University, she held the position of Scientific Director of the Utrecht Institute for Pharmaceutical Sciences from November 2018 to February 2023, became Vice-Dean of Research for the Faculty of Science in February 2023, and was appointed interim Dean of the Faculty of Science in February 2026. Her leadership extends to co-chairing the Utrecht Advanced In Vitro Models Hub (U-AIM) and serving as president of the Dutch Pharmacological Society.

Masereeuw's research focuses on experimental pharmacology, particularly renal drug transporters, nephrotoxicity, and regenerative medicine. Her group unravels molecular interactions in organ systems using humanized in vitro models, including patented human renal proximal tubule cell lines and organ-on-a-chip technologies mimicking kidney and intestine functions for studying drug disposition, toxicity, and repair pathways. Key projects include the EU-funded RenalToolBox for cell-based kidney therapies, RESCUE training network on regenerative medicine, and Drug disposition On-a-Chip for ADME/PK modeling. She has authored over 270 peer-reviewed publications, book chapters, and reviews, with highly cited works such as 'Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules' (2008), 'Tubuloids derived from human adult kidney and urine for personalized disease modeling' (2019), and 'Kidney-on-a-chip technology for drug-induced nephrotoxicity screening' (2016). Her innovations contribute to bioartificial kidney development and improved drug safety testing. Masereeuw has received the Dutch Pharmacological Society Schering-Plough Award (2009), Galenus Research Prize (2010), American Association of Pharmaceutical Scientists Fellowship (2015), Supervisor of the Year at Utrecht University's Graduate School of Life Sciences (2018), and election to the Royal Holland Society of Sciences and Humanities (2022). She has presented at international conferences including those of IUPHAR, AAPS, ISSX, and the British Pharmacological Society.